Apple Unveils $1,999 Foldable iPhone Duo 
German Inflation Accelerates to 2.9% in August 
UK Food Inflation Forecast to Hit 6.4% by Mid-2027 
The Beauty Beneath the Expressway: A Journey from Self to Service 
Anthropic Drops $6 Billion Decart AI Acquisition Talks 
What’s the difference between baking powder and baking soda? It’s subtle, but significant 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
The American mass exodus to Canada amid Trump 2.0 has yet to materialize 
China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit 
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 
Novartis M&A Strategy Faces Investor Scrutiny After Drug Setbacks 
Longsys Raises $903 Million in Hong Kong IPO as Shares Debut Flat 
U.S. Accuses Chinese AI Firms of Extracting Model Capabilities 
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain 
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe 
Add as a preferred source on Google
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
